{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T21:11:59Z","timestamp":1724965919741},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,10,15]]},"DOI":"10.2169\/internalmedicine.1005-18","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T18:30:30Z","timestamp":1526581830000},"page":"3047-3050","source":"Crossref","is-referenced-by-count":5,"title":["Cytomegalovirus Hemorrhagic Cystitis in a Malignant Glioma Patient Treated with Temozolomide"],"prefix":"10.2169","volume":"57","author":[{"given":"Ryutaro","family":"Furukawa","sequence":"first","affiliation":[{"name":"Division of Respirology, NTT Medical Center Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokuni","family":"Homma","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, NTT Medical Center Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, NTT Medical Center Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Horiuchi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, NTT Medical Center Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Usui","sequence":"additional","affiliation":[{"name":"Division of Respirology, NTT Medical Center Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Stupp R, Mason WP, Van Den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005.","DOI":"10.1056\/NEJMoa043330"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131: 803-820, 2016.","DOI":"10.1007\/s00401-016-1545-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Grossman SA, Ye X, Lesser G, et al. Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide. Clin Cancer Res 17: 5473-5480, 2011.","DOI":"10.1158\/1078-0432.CCR-11-0774"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Campian JL, Piotrowski AF, Ye X, et al. Serial changes in lymphocyte subsets in patients with newly diagnosed high grade astrocytomas treated with standard radiation and temozolomide. J Neurooncol 135: 1-9, 2017.","DOI":"10.1007\/s11060-017-2580-z"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Olnes MJ, Kotliarov Y, Biancotto A, et al. Effects of systemically administered hydrocortisone on the human immunome. Sci Rep 6: 23002, 2016.","DOI":"10.1038\/srep23002"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Su YB, Sohn S, Krown SE, et al. Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. J Clin Oncol 22: 610-616, 2004.","DOI":"10.1200\/JCO.2004.07.060"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yu SK, Chalmers AJ. Patients receiving standard-dose temozolomide therapy are at risk of <i>Pneumocystis carinii<\/i> pneumonia. Clin Oncol 19: 631-632, 2007.","DOI":"10.1016\/j.clon.2007.06.003"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fujimoto Y, Hashimoto N, Kinoshita M, et al. Hepatitis B virus reactivation associated with temozolomide for malignant glioma: a case report and recommendation for prophylaxis. Int J Clin Oncol 17: 290-293, 2012.","DOI":"10.1007\/s10147-011-0294-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ikeda T, Suzuki J, Norizuki M, et al. Cutaneous invasive aspergillosis in a patient with glioblastoma receiving long-term temozolomide and corticosteroid therapy. J Infect Chemother 23: 253-255, 2017.","DOI":"10.1016\/j.jiac.2016.10.004"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Choi JD, Powers CJ, Vredenburgh JJ, Friedman AH, Sampson JH. Cryptococcal meningitis in patients with glioma: a report of two cases. J Neurooncol 89: 51-53, 2008.","DOI":"10.1007\/s11060-008-9581-x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Aregawi D, Lopez D, Wick M, Scheld WM, Schiff D. Disseminated strongyloidiasis complicating glioblastoma therapy: a case report. J Neurooncol 94: 439-443, 2009.","DOI":"10.1007\/s11060-009-9878-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Meije Y, Lizasoain M, Garc\u00eda-Reyne A, et al. Emergence of cytomegalovirus disease in patients receiving temozolomide: report of two cases and literature review. Clin Infect Dis 50: e73-e76, 2010.","DOI":"10.1086\/653011"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Schwarzberg AB, Stover EH, Sengupta T, et al. Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide. Cancer Invest 25: 249-255, 2007.","DOI":"10.1080\/07357900701206380"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Yaman E, Coskun U, Ozturk B, et al. Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma. J Clin Neurosci 16: 591-592, 2009.","DOI":"10.1016\/j.jocn.2008.05.030"},{"key":"15","unstructured":"15. Jesus A De, Grossman SA, Paun O. Cytomegalovirus associated colonic pseudotumor: a consequence of iatrogenic immunosuppression in a patient with primary brain tumor receiving radiation and temozolomid. NIH Public Access 94: 445-448, 2013."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Douzinas EE, Flevari K, Andrianakis I, Betrosian AP. Oral atovaquone for the treatment of severe <i>Pneumocystis jirovecii<\/i> pneumonia in a patient with glucose-6-phosphate dehydrogenase deficiency. Scand J Infect Dis 42: 76-78, 2010.","DOI":"10.3109\/00365540903321606"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Okita Y, Narita Y, Miyakita Y, Ohno M, Nagai S, Shibui S. Management of cytomegalovirus infection in a patient with malignant glioma treated with temozolomide and steroids. Intern Med 51: 2967-2971, 2012.","DOI":"10.2169\/internalmedicine.51.8378"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Whitley RJ, Jacobson MA, Friedberg DN, et al. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med 158: 957-969, 1998.","DOI":"10.1001\/archinte.158.9.957"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lee G, Romih R, Zupan\u010di\u010d D. Cystitis: From urothelial cell biology to clinical applications. Biomed Res Int 2014: 473536, 2014.","DOI":"10.1155\/2014\/473536"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Mohammadianpanah M, Shirazi M, Mosalaei A, Omidvari S, Ahmadloo N. Hemorrhagic cystitis in a patient receiving conventional doses of dacarbazine for metastatic malignant melanoma: case report and review of the literature. Clin Ther 29: 1161-1165, 2007.","DOI":"10.1016\/j.clinthera.2007.06.004"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Islam R, Isaacson BJ, Zickerman PM, Ratanawong C, Tipping SJ. Hemorrhagic cystitis as an unexpected adverse reaction to temozolomide: case report. Am J Clin Oncol 25: 513-514, 2002.","DOI":"10.1097\/00000421-200210000-00018"},{"key":"22","unstructured":"22. Stella F, Battistelli S, Marcheggiani F, et al. Urothelial cell changes due to busulfan and cyclophosphamide treatment in bone marrow transplantation. Acta Cytol 34: 885-890, 1990."},{"key":"23","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/00002030-200207050-00024","volume":"16","author":"A Studemeister","year":"2002","unstructured":"23. Studemeister A. Cytomegalovirus-induced hemorrhagic cystitis in AIDS patient treated successfully with valganciclovir. AIDS 16: 1437-1438, 2002.","journal-title":"AIDS","ISSN":"http:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ersan S, Yorukoglu K, Sert M, et al. Unusual case of severe late-onset cytomegalovirus-induced hemorrhagic cystitis and ureteritis in a renal transplant patient. Ren Fail 34: 247-250, 2012.","DOI":"10.3109\/0886022X.2011.647209"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Sahu KK, Prakash G, Khadwal A, Varma SC, Malhotra P. A rare case of hemorrhagic cystitis in allogeneic hematopoietic stem cell transplant patient. Indian J Hematol Blood Transfus 32: 196-200, 2016.","DOI":"10.1007\/s12288-015-0530-5"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Han TT, Xu LP, Liu DH, et al. Cytomegalovirus is a potential risk factor for late-onset hemorrhagic cystitis following allogeneic hematopoietic stem cell transplantation. Am J Hematol 89: 55-61, 2014.","DOI":"10.1002\/ajh.23584"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/20\/57_1005-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:56:28Z","timestamp":1539996988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/20\/57_1005-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":26,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1005-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]}}}